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Aims The mechanism of the action of flecainide in the termination of human atrial fibrillation (AF) is not fully understood.
We studied the acute effects of flecainide on AF electrograms in the time and frequency domain to identify factors
associated with AF termination.
Methods
and results
Patients who were still in AF at the end of catheter ablation for AF were given intravenous flecainide. Dominant fre-
quency (DF) and organization index (OI) were obtained by fast Fourier transform of electrograms from the coronary
sinus catheter over 10 s in AF, before and after flecainide infusion. Mean AF cycle length (CL) was also calculated.
Twenty-six patients were studied (16 paroxysmal AF and 10 persistent AF). Seven converted to sinus rhythm
(SR) with flecainide. In all patients, mean CL increased from 211+44 to 321+ 85 ms (P, 0.001). Mean DF
decreased from 5.2+1.03 to 3.6+1.04 Hz (P, 0.001). Mean OI was 0.33+ 0.13 before and 0.32+ 0.11 after fle-
cainide (P ¼ 0.90). Comparing patients who converted to SR with those who did not, OI post-flecainide was
0.41+ 0.12 vs. 0.29+ 0.10 (P ¼ 0.013), and the relative change in OI was 29+ 33 vs. 23.9+27% (P ¼ 0.016),
respectively. No significant difference was noted in the change in CL and DF in the two groups.
Conclusion Increase in OI, independent of changes to CL and DF, appears critical to AF termination with flecainide. Increase in OI
holds promise as a sensitive predictor of AF termination.
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Introduction
Despite their widespread use in the treatment of atrial fibrillation
(AF), the mechanism by which Class Ic anti-arrhythmic drugs ter-
minate AF is not well understood. Early studies on the effects of
flecainide1 and propafenone2 in canine AF suggested that the ter-
mination of AF was the result of a rate-dependent increase in atrial
effective refractory period, which led to an overall increase in
wavelength. However, more recent work on goat AF failed to
show this relationship, but instead, found that widening of the tem-
poral excitable gap to be consistently associated with AF
termination with flecainide, as was the case with several other anti-
arrhythmic drugs used in the study.3 These studies utilized AF
induction protocols in different animals, and also employed differ-
ent methods of measuring atrial refractory periods, which make
direct comparison difficult. Moreover, none of these proposed
theories of pharmacological AF termination have been adequately
tested in human AF, the mechanism of which remains incompletely
understood.
Recent studies of intracardiac signals during catheter ablation for
AF in humans have suggested that the prolongation of AF cycle
length (CL)4 and increased organization5 of AF are associated
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with return to sinus rhythm (SR). Whether these observations can
also reliably predict pharmacological termination of human AF is
unclear. To gain greater understanding into the mechanism of AF
termination using Class Ic anti-arrhythmic drugs, we used flecainide
to assess its effect on time and frequency domain characteristics of
human AF, using intracardiac signal analysis. We hypothesized that
flecainide will prolong AF CL, reduce the dominant frequency (DF)
of AF, as well as increase its organization prior to termination.
Methods
Patients who were given flecainide during catheter ablation for AF
were studied. All documented AF during the ablation procedures
were either spontaneous or already pre-existent. No programmed
AF induction was carried out in any patient. Paroxysmal AF is
defined as AF that terminates spontaneously within 7 days, whereas
persistent AF is defined as AF which is sustained beyond 7 days or
lasting less than 7 days but requiring pharmacological or electrical car-
dioversion. All anti-arrhythmic therapy was discontinued for more than
five half-lives prior to the procedure.
Atrial fibrillation ablation was carried out using bilateral femoral
venous access. Under fluoroscopic guidance, a deflectable decapolar
catheter and a quadripolar catheter were positioned in the coronary
sinus and His position, respectively. A circular pulmonary vein
mapping catheter and a deflectable, irrigated tip ablation catheter
were advanced into the left atrium after transseptal puncture. Standard
segmental ostial pulmonary vein isolation alone (n ¼ 13) was per-
formed in patients with paroxysmal AF. More extensive ablation was
carried out in patients with persistent AF or when paroxysmal AF
failed to terminate with segmental ostial pulmonary vein isolation
alone. This consisted of either segmental ostial pulmonary vein iso-
lation with linear ablation, followed by complex fractionated electro-
gram ablation (n ¼ 10), or wide area circumferential ablation
followed by linear ablation (n ¼ 3). In all cases, left atrial anatomical
geometry was created using EnSite NavXTM electroanatomical
mapping (St Jude Medical Inc., St Paul, MN, USA). Patients who
remained in AF at the end of the ablation procedure (either in AF at
the start or developed AF during ablation) were given flecainide.
This was administered at a dose of 2 mg/kg body mass (maximum of
150 mg) as intravenous infusion over 10 min, followed by observation
for 10 min for any change in cardiac rhythm.
Time and frequency domain analyses
Intra-cardiac electrograms were recorded on a 30–500 Hz filter with a
sampling frequency of 1 kHz (Labsystem Pro, Bard Electrophysiology,
Lowell, MA, USA). Time and frequency domain analyses were
carried out offline. Analysis was carried out on bipolar AF electro-
grams recorded from the decapolar catheter in the coronary sinus
at the end of catheter ablation for AF. All electrograms with good
signal quality on the decapolar catheter were analysed. Readings
were taken prior to flecainide infusion, as well as after the full dose
of flecainide had been given. In the event of return to SR after flecai-
nide infusion, electrograms just prior to rhythm change were analysed.
Cycle length measurements were carried out using built-in autodetec-
tion software (Labsystem Pro) and also verified manually. Mean CL was
calculated over a 10 s recording period. The same 10 s segment was
exported and analysed using fast Fourier transform with a spectral res-
olution of 0.24 Hz (4096 points), after processing with a Hamming
window. A 1024 point sliding window was used to give the mean
DF and mean organization index (OI) of the signal. The DF is
defined as the frequency with the tallest peak in the power spectrum,6
and OI was derived by dividing the area under the DF and its harmo-
nics by the total power of the frequency spectrum.5
Statistical analysis
All continuous variables are expressed as mean+ standard deviation.
Normally distributed data were analysed using paired and unpaired
Student’s t-test as appropriate. Categorical data were analysed using
x2 or Fisher’s exact test. Logistic regression was carried out to identify
independent predictors of outcome after flecainide infusion, and recei-
ver operator characteristic analysis was used to evaluate the relevant
parameter. A P-value of ,0.05 was considered statistically significant.
Results
A total of 26 patients were included in the study. Sixteen (62%)
had paroxysmal AF and 10 (38%) had persistent AF. Four of the
patients with paroxysmal AF were in AF at the start of the pro-
cedure, whereas the remaining 12 developed AF spontaneously
during the procedure. All patients with persistent AF started the
procedure in AF. Seven (27%) converted to SR with flecainide (6
paroxysmal AF, 1 persistent AF). Average time to cardioversion
with flecainide was 252+96 s after initiating the infusion. Taking
all patients together, mean CL increased from 211+44 to
321+85 ms (P, 0.001) after flecainide. Mean DF decreased
from 5.2+1.03 to 3.6+ 1.04 Hz (P, 0.001). The mean OI
remained unchanged [0.33+ 0.13 before and 0.32+ 0.11 after fle-
cainide (P ¼ 0.90)]. The inverse of the DF (1000/DF) revealed a
strong linear relationship with mean CL (Pearson correlation
coefficient ¼ 0.90, P, 0.001) (Figure 1). Representative examples
of intracardiac recordings and frequency spectrum analysed for
this study are shown in Figures 2 and 3. Figure 2 shows data on
the electrocardiogram (ECG) (lead V1) and intracardiac electro-
grams before and after intravenous flecainide in a patient whose
AF did not terminate with flecainide together with the correspond-
ing spectral data from FFT analysis, whereas Figure 3 shows the
Figure 1 Plot of mean cycle length during atrial fibrillation and
the inverse of corresponding dominant frequency (1000/DF) in all
patients with and without intravenous flecainide showing a linear
relationship between the two parameters (Pearson correlation
coefficient 0.90, P, 0.001).
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Figure 2 Typical example of a patient (Patient A) in whom atrial fibrillation did not terminate with intravenous flecainide. The left hand panels
show electrocardiogram lead V1 and intracardiac electrograms before and after flecainide. The right-hand panels show the corresponding fre-
quency spectra, with dominant frequency decreasing from 5.4 to 2.7 Hz, but organization index showed little change (0.26 pre- and 0.24 post-
flecainide) with flecainide.
Figure 3 Typical example of a patient (Patient B) in whom atrial fibrillation terminated with intravenous flecainide. The left-hand panels show
electrocardiogram lead V1 and intracardiac electrograms before and after flecainide and after returning to sinus rhythm. The right-hand panels
show the corresponding frequency spectra with dominant frequency decreasing from 4.6 to 2.9 Hz and organization index increased from 0.27
to 0.39 before return to sinus rhythm.
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same analysis in a patient whose AF converted to SR with
flecainide.
Comparing patients who converted to SR after flecainide with
those who remained in AF, OI post-flecainide was 0.41+0.12
vs. 0.29+ 0.10 (P ¼ 0.013), and relative change in OI was 29+
33 vs. 23.9+ 27% (P ¼ 0.016), respectively. No significant differ-
ences were noted in the mean CL and DF post-flecainide, and simi-
larly, no significant differences were seen in the relative change in
CL and DF in the two groups. Mean CL post-flecainide was 335+
90 vs. 315+ 85 ms (P ¼ 0.61), mean DF was 3.2+0.9 vs. 3.8+
1.1 Hz (P ¼ 0.20), relative change in CL was 76+64 vs.
48+ 34% (P ¼ 0.16) and relative change in DF 237+ 24 vs.
225+ 19% (P ¼ 0.21), when comparing patients who returned
to SR after flecainide with those who stayed in AF, respectively.
There were no significant differences in the CL, DF, or OI
between the two groups prior to flecainide administration.
Detailed characteristics of the study patients can be found in
Table 1. Logistic regression analysis identified that a greater relative
increase in OI (P ¼ 0.04), a higher OI post-flecainide (P ¼ 0.03),
and SR at the start of procedure (P ¼ 0.03) to be independently
associated with successful reversion to SR with flecainide. Receiver
operator characteristic curves indicate that an OI of .0.33 and a
relative increase in OI of .14.8% independently have a 71% sen-
sitivity and 79% specificity for identifying those who will return to
SR after flecainide administration [area under curve 0.82 (P ¼ 0.01)
and 0.77 (P ¼ 0.03), respectively].
Discussion
This study shows, using spectral analysis of intracardiac electro-
grams, that the mechanism of human AF termination by flecainide
is critically preceded by organization of the arrhythmia, as reflected
by an increase in OI. Although CL prolongation and corresponding
reduction in DF occurred with flecainide administration, they did
not predict return to SR. This suggests that an increase in the
organization of AF is a more sensitive predictor of cardioversion
to SR than the change in DF or CL.
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Table 1 Patient characteristics
Successful termination of AF with
flecainide (n 5 7)
Failed termination of AF with
flecainide (n5 19)
P-value
Age 48+9 55+11 P ¼ 0.14
Sex (male), n (%) 6 (86) 14 (74) P ¼ 0.65
Paroxysmal AF, n (%) 6 (86) 10 (53) P ¼ 0.19
Persistent AF, n (%) 1 (14) 9 (47)
Hypertension, n (%) 4 (57) 8 (42) P ¼ 0.67
Ejection fraction (%) 52+5 54+3 P ¼ 0.28
Left atrial dimension (cm) (parasternal
measurement)
4.1+0.6 4.3+0.6 P ¼ 0.66
Rhythm at the start of the procedure, n (%)
SR 6 (86) 6 (32) P ¼ 0.026
AF 1 (14) 13 (68)
Ablation strategy
PVI alone 4 9 P ¼ 0.53
PVI þ CFE ablation 3 7
WACA 0 3
Total ablation times (s) 2963+882 3424+1809 P ¼ 0.52
CL pre-flecainide 202+52 214+42 P ¼ 0.53
CL post-flecainide 335+90 316+85 P ¼ 0.61
Absolute change 134+100 101+71 P ¼ 0.37
%Change in CL 76+64 48+34 P ¼ 0.16
DF pre-flecainide 5.4+1.4 5.1+0.9 P ¼ 0.59
DF post-flecainide 3.2+0.89 3.8+1.1 P ¼ 0.20
Absolute change 22.2+1.7 21.33+1.0 P ¼ 0.12
%Change in DF 237+24 225+19 P ¼ 0.21
OI pre-flecainide 0.33+0.11 0.32+0.13 P ¼ 0.90
OI post-flecainide 0.41+0.12 0.29+0.1 P ¼ 0.013*
Absolute change 0.08+0.11 20.03+0.1 P ¼ 0.017*
%Change in OI 29+33 23.9+27 P ¼ 0.016*
PVI, pulmonary vein isolation (segmental ostial); CFE, complex fractionated electrograms; WACA, wide area circumferential ablation; CL, cycle length; DF, dominant frequency;
OI, organization index.
*P, 0.05 considered significant.
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Mechanism of atrial fibrillation
termination with flecainide
According to the multiple wavelet hypothesis proposed by Moe
and Abildskov,7 AF is the result of multiple wavelets of re-entrant
circuits propagating throughout the atria. The relationship between
re-entry and wavelength was first described by Mines8 and also
subsequently by Lewis.9 Wavelength can be described as the
minimal pathlength that supports re-entry. This has been formu-
lated mathematically by Wiener and Rosenblueth,10 who showed
that wavelength (WL) [defined as a product of refractory period
(RP) and conduction velocity (CV): WL ¼ RP  CV] critically
determined the likelihood of re-entry. The greater the wavelength,
the smaller the number of re-entrant circuits the atria can contain,
hence reducing the likelihood of AF being sustained. The use of
wavelength as an index to predict susceptibility to atrial arrhythmia
has been studied previously by Rensma et al.11 and found to be
predictive in 75% of cases, making it a useful way to assess anti-
arrhythmic potential of drugs.
This concept has led to the question of how Class Ic anti-
arrhythmic drugs, which block sodium channels and decrease con-
duction velocity without any apparent effect on refractory period,
can result in the termination of AF. Wang et al.12 examined the
response of human atrial tissue to flecainide and found that it
increased atrial action potential duration and refractoriness
enhanced by the rapid rates typical of AF. In a separate study,
Wang et al.1 demonstrated in a dog vagal AF model that flecainide
terminated AF by causing a tachycardia-dependent increase in atrial
effective refractory period (to a greater extent than reduction in
conduction velocity) which increased the wavelength. This same
study also showed that flecainide progressively increased the size
and reduced the number of re-entry circuits, as well as slowing
atrial activation until AF terminated.
However, the theory that flecainide and Class Ic anti-arrhythmic
drugs in general can influence wavelength changes has been put in
question by other studies. Using a goat chronic AF model, Wijffels
et al.3 found that Class I agents (flecainide and cibenzoline) actually
shortened the wavelength of AF, and widening of the temporal
excitable gap was the only finding associated with pharmacological
cardioversion of AF. An earlier study on flecainide in humans13 also
failed to show any significant effect on atrial refractoriness. Simi-
larly, Katristis et al.14 found no change in atrial effective refractory
period with flecainide infusion and pacing at different CLs in human
subjects.
Using a mathematical model of AF, Kneller et al.15 found that
pure sodium channel blockade terminated AF despite reducing
wavelength, and likely mechanisms include the enlargement of
the core size of primary rotors, increasing meander and extinction
at boundaries, and reduction in the number of wavelets.
Frequency domain analysis of atrial
fibrillation
Using spectral analysis of canine AF, Everett et al.16 showed that
high AF organization increased the efficacy of burst pace termin-
ation and also electrical cardioversion17 of AF.
Bollmann et al.18 studied the use of oral flecainide in patients
with persistent AF by carrying out frequency spectrum analysis
on high-resolution surface ECG recordings. A lower fibrillatory
frequency post-flecainide and smaller left atrial size were found
to predict restoration of SR. Using a similar technique, Husser
et al.19 carried out time-frequency analysis of surface ECG of AF
to compare the effects of flecainide and amiodarone with baseline.
A reduction in both fibrillatory rate (converted from DF) and also
exponential decay of the frequency spectrum were seen after drug
administration, with effects more apparent in the flecainide group.
The authors suggested that the decrease in exponential decay,
seen with both flecainide and amiodarone, reflected organization
of AF and was analogous to an increase in OI.
Atrial fibrillation cycle length analysis
Atrial fibrillation CL is generally thought to reflect local atrial
refractoriness.20 However, assessing the exact mechanism of AF
CL prolongation in the setting of flecainide administration is diffi-
cult as it is believed to have a use-dependent effect on atrial refrac-
toriness and conduction velocity,1,12,21 both of which can result in
an increase in AF CL. Biffi et al.22 studied induced AF in 10 patients
with paroxysmal AF. The mean of 100 consecutive AF intervals
(measured from endocardial electrograms) was increased by
both flecainide and propafenone prior to AF termination in all
the study patients. All 10 patients returned to SR within 10 min
of drug administration. The authors also remarked that the
extent of AF interval prolongation occurred to a greater extent
with drugs than with that observed in self-terminating AF in a pre-
vious study,23 also carried out by the same group.
Implication of findings
The mechanism of AF termination with sodium channel blockade
remains poorly understood. Using spectral analysis, we have
demonstrated, in human subjects, that AF CL prolonged and DF
reduced uniformly after flecainide administration; however, this
did not predict return to SR. Reversion to SR with flecainide
was independently associated with a higher OI post-flecainide
and also a greater relative rise in OI induced by flecainide, regard-
less of change in CL or DF. This suggests that the process of AF
termination depends critically on an increase in the organization
of the arrhythmia, possibly even more crucially so than slowing
of atrial activation. This implies that increase in the organization
of AF is likely to be a more sensitive predictor of return to SR
than the change in DF or CL. Although other studies have
shown AF CL prolongation with Class Ic anti-arrhythmics, none
have used spectral analysis to quantify the organization of the
rhythm and its relationship with return to SR in human AF.
A higher OI is a marker of greater regularity. The increase in OI
seen in our study can be hypothesized to reflect a reduction in the
number of re-entrant circuits or drivers, prior to AF termination.
When coupled with the increase in AF CL and reduction in DF
(and hence slowing of atrial activation rate), it results in conditions
favourable for return to SR. An isolated increase in AF CL or
reduction in DF alone, with no increase in organization, probably
represents continued presence of multiple re-entrant circuits or
drivers which reduces the likelihood of return to SR.
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Limitations
Our study reflects the behaviour of the ablated left atrium.
However, it is probably not dissimilar to the spectral character-
istics of the unablated left atrium since ablation alone was not suf-
ficient to achieve termination of AF in these patients, implying the
continued presence of unaddressed drivers or substrate maintain-
ing AF.
Using a catheter placed in the coronary sinus has the advantage
of stability in terms of positioning, but we acknowledge that the
electrograms recorded from this catheter are not directly from
within the left atrium and do not fully assess the global spatiotem-
poral characteristics of AF. However, in the context of assessing
CL and spectral characteristics of human AF, the utilization of cor-
onary sinus electrograms alone for analysis is well described in
published literature,4,5,24,25 and although it has its limitations, it
seems to be an acceptable technique.
Though not achieving statistical significance, there appears to be
a trend suggesting that CL and DF changes may be greater in those
who returned to SR after flecainide than those who did not. Owing
to the small sample size, the study is not powered to conclusively
exclude any link in CL and DF changes with the likelihood of
returning to SR, although it still supports the notion that increase
in OI is a more sensitive indicator.
Conclusion
Our findings provide an insight into the controversial mechanism of
human AF termination with Class Ic agents such as flecainide. The
spectral characteristics observed in our study appear to support
findings reported by researchers using canine AF1 and mathematical
AF models.15 Similarly, our findings also reflect observations from
the termination of AF with catheter ablation,5 burst pacing,16 and
electrical cardioversion,17 adding further weight to the evidence
that increased spectral organization plays a crucial role in AF termin-
ation, regardless of the method used to achieve this. The OI of AF
appears to be a useful tool to assess for the likelihood of AF termin-
ation and may be useful as a target for development of AF therapy.
Larger studies into spectral organization of AF are needed to further
define its significance in human AF.
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